MicroRNA-126 Inhibits Cell Viability and Invasion in a Diabetic Retinopathy Model Via Targeting IRS-1

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Sep 26

PMID 28943945

Citations 19

Authors

Shifeng Fang

Xiang Ma

Suping Guo

Jianmin Lu

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) is a sight-threatening complication of diabetes. IRS-1 was predicted to be the target gene of microRNA-126 (miR-126). The present study was designed to illustrate the involvement of miR-126 in the regulation of DR via targeting IRS-1. The present study revealed that the expression of miR-126 was significantly decreased while IRS-1 expression was increased in endothelial cells (ECs) and retinal pericytes (RPs) from a DR mouse model compared with healthy controls. Furthermore, a luciferase reporter assay confirmed the interaction between miR-126 and IRS-1. Following transfection with anmiR-126 mimic or miR-126 inhibitor, overexpression of miR-126 was demonstrated to suppress the invasion and viability of ECs and RPs and to inhibit the IRS-1 and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway protein expression levels, with inhibition of miR-126 leading to reverse results. Furthermore, transfection with small interfering RNA targeting IRS-1 altered the miR-126-induced effects observed in ECs, indicating that miR-126 may suppress angiogenesis in DR via inhibition of IRS-1 expression. Taken together, the results of the present study suggested that miR-126 affected the expression of IRS-1, resulting in downregulated expression of PI3K/Akt pathway proteins, and also suppressed cell invasion and viability. These results may provide a potential therapeutic strategy for DR.

Citing Articles

Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis.

Wilson T, Baghel M, Kaur N, Datta I, Loveless I, Potla P Nat Commun. 2025; 16(1):2021.

PMID: 40016267 PMC: 11868599. DOI: 10.1038/s41467-025-57308-5.

MicroRNA-126 (MiR-126): key roles in related diseases.

Liao L, Tang Y, Zhou Y, Meng X, Li B, Zhang X J Physiol Biochem. 2024; 80(2):277-286.

PMID: 38517589 DOI: 10.1007/s13105-024-01017-y.

Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives.

Aghaei-Zarch S Noncoding RNA Res. 2024; 9(2):486-507.

PMID: 38511053 PMC: 10950585. DOI: 10.1016/j.ncrna.2024.01.005.

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.

Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A Int J Mol Sci. 2024; 25(4).

PMID: 38396799 PMC: 10889839. DOI: 10.3390/ijms25042124.

Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy.

Li J, Chen K, Li X, Zhang X, Zhang L, Yang Q Cell Death Discov. 2023; 9(1):418.

PMID: 37978169 PMC: 10656479. DOI: 10.1038/s41420-023-01717-2.

References

Poulaki V, Qin W, Joussen A, Hurlbut P, Wiegand S, Rudge J . Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest. 2002; 109(6):805-15. PMC: 150907. DOI: 10.1172/JCI13776. View

Armulik A, Abramsson A, Betsholtz C . Endothelial/pericyte interactions. Circ Res. 2005; 97(6):512-23. DOI: 10.1161/01.RES.0000182903.16652.d7. View

Figliolini F, Cantaluppi V, De Lena M, Beltramo S, Romagnoli R, Salizzoni M . Isolation, characterization and potential role in beta cell-endothelium cross-talk of extracellular vesicles released from human pancreatic islets. PLoS One. 2014; 9(7):e102521. PMC: 4100900. DOI: 10.1371/journal.pone.0102521. View

Meng S, Cao J, Zhang B, Zhou Q, Shen C, Wang C . Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012; 53(1):64-72. DOI: 10.1016/j.yjmcc.2012.04.003. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Bandello F, Lattanzio R, Zucchiatti I, Del Turco C . Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol. 2013; 50(1):1-20. DOI: 10.1007/s00592-012-0449-3. View

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

Park S, Yun J, Kim J, Kim K, Cho C, Kim J . Angiopoietin 2 induces pericyte apoptosis via α3β1 integrin signaling in diabetic retinopathy. Diabetes. 2014; 63(9):3057-68. DOI: 10.2337/db13-1942. View

Liang D, Zhong P, Hu J, Lin F, Qian Y, Xu Z . EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. J Mol Cell Cardiol. 2015; 82:63-74. DOI: 10.1016/j.yjmcc.2015.02.029. View

10.

Buzney S, Massicotte S, Hetu N, Zetter B . Retinal vascular endothelial cells and pericytes. Differential growth characteristics in vitro. Invest Ophthalmol Vis Sci. 1983; 24(4):470-80. View

11.

Carlsson P, Jansson L . Disruption of insulin receptor signaling in endothelial cells shows the central role of an intact islet blood flow for in vivo β-cell function. Diabetes. 2015; 64(3):700-2. DOI: 10.2337/db14-1523. View

12.

Zhang J, Du Y, Lin Y, Chen Y, Yang L, Wang H . The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun. 2008; 377(1):136-40. DOI: 10.1016/j.bbrc.2008.09.089. View

13.

King G, Goodman A, Buzney S, Moses A, Kahn C . Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1985; 75(3):1028-36. PMC: 423655. DOI: 10.1172/JCI111764. View

14.

Hoeppner L, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X . RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells. J Cell Sci. 2015; 128(19):3556-68. PMC: 4647168. DOI: 10.1242/jcs.167601. View

15.

Wang S, Aurora A, Johnson B, Qi X, McAnally J, Hill J . The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008; 15(2):261-71. PMC: 2685763. DOI: 10.1016/j.devcel.2008.07.002. View

16.

Cesarone G, Garofalo C, Abrams M, Igoucheva O, Alexeev V, Yoon K . RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem. 2006; 98(2):440-50. DOI: 10.1002/jcb.20817. View

17.

Congdon N, Friedman D, Lietman T . Important causes of visual impairment in the world today. JAMA. 2003; 290(15):2057-60. DOI: 10.1001/jama.290.15.2057. View

18.

Ryu H, Park S, Ma D, Zhang J, Lee W . The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS One. 2011; 6(3):e17343. PMC: 3064581. DOI: 10.1371/journal.pone.0017343. View

19.

Behl T, Kotwani A . Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy. Pharmacol Res. 2015; 99:137-48. DOI: 10.1016/j.phrs.2015.05.013. View

20.

. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26(12):3333-41. DOI: 10.2337/diacare.26.12.3333. View